Ameriprise Financial Inc Adma Biologics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 627,130 shares of ADMA stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

627,130

Previous 122,773 410.8%

Holding current value

$11.6 Million

Previous $1.37 Million 813.7%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.21 - $20.03 $5.65 Million - $10.1 Million	504,357 Added 410.8%	627,130 $12.5 Million
Q2 2024 Aug 14, 2024	SELL	$5.98 - $11.18 $578,654 - $1.08 Million	-96,765 Reduced 44.08%	122,773 $1.37 Million
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $567,028 - $868,583	-128,870 Reduced 36.99%	219,538 $1.45 Million
Q4 2023 Feb 14, 2024	SELL	$3.08 - $4.52 $218,470 - $320,612	-70,932 Reduced 16.92%	348,408 $1.57 Million
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $57,719 - $76,682	16,634 Added 4.13%	419,340 $1.5 Million
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $102,473 - $138,601	32,844 Added 8.88%	402,706 $1.49 Million
Q1 2023 May 15, 2023	SELL	$3.01 - $3.87 $1,113 - $1,431	-370 Reduced 0.1%	369,862 $1.22 Million
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $9,692 - $15,225	-3,924 Reduced 1.05%	370,232 $1.44 Million
Q3 2022 Nov 14, 2022	SELL	$2.03 - $2.86 $23,176 - $32,652	-11,417 Reduced 2.96%	374,156 $910,000
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $551,369 - $848,260	385,573 New	385,573 $764,000
Q1 2021 May 17, 2021	SELL	$1.67 - $2.95 $35,738 - $63,130	-21,400 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$1.8 - $2.56 $49,104 - $69,836	-27,280 Reduced 56.04%	21,400 $44,000
Q3 2020 Nov 16, 2020	BUY	$2.04 - $3.74 $4,630 - $8,489	2,270 Added 4.89%	48,680 $116,000
Q2 2020 Aug 14, 2020	BUY	$2.42 - $3.29 $34,146 - $46,421	14,110 Added 43.68%	46,410 $136,000
Q1 2020 May 15, 2020	BUY	$1.5 - $4.59 $13,050 - $39,933	8,700 Added 36.86%	32,300 $93,000
Q4 2019 Feb 14, 2020	SELL	$3.89 - $5.15 $87,155 - $115,385	-22,405 Reduced 48.7%	23,600 $94,000
Q3 2019 Nov 14, 2019	SELL	$3.19 - $5.39 $10,830 - $18,299	-3,395 Reduced 6.87%	46,005 $205,000
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $173,888 - $258,856	49,400 New	49,400 $191,000

Others Institutions Holding ADMA

# of Institutions

318

Shares Held

184M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.62B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Adma Biologics, Inc. Transaction History